We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


PBL Signs License Agreement with Thermo Fisher

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "PBL Signs License Agreement with Thermo Fisher"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Plant Bioscience Limited (PBL) has announced that it has entered into a licensing agreement that grants Thermo Fisher Scientific a world-wide, non-exclusive license to the Baulcombe patents for use in the field of research reagents and kits.

PBL’s Managing Director Dr Jan Chojecki, stated: “We are very pleased to enter into this agreement with Thermo Fisher, a global leader in research reagents based on RNA interference and detecting gene silencing. Thermo Fisher has an excellent product portfolio in this important and growing area of science. We look forward to working with other partners through our non-exclusive licensing strategy in agricultural, research, diagnostic and therapeutic commercial applications. We are pleased to be able to make non-exclusive licenses available on reasonable commercial terms to assist our partners in all areas of RNAi.”